Staging accuracy of pancreatic cancer: Comparison between non-contrast-enhanced and contrast-enhanced PET/CT
Abstract Purpose Our aim was to clarify the diagnostic impact of contrast-enhanced (CE)18 F-fluorodeoxyglucose (FDG)–positron emission tomography (PET)/computed tomography (CT) for staging of pancreatic cancer compared to non-CE PET/CT. Method and materials Between April 2006 and November 2009, a to...
Saved in:
Published in | European journal of radiology Vol. 83; no. 10; pp. 1734 - 1739 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier Ireland Ltd
01.10.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Purpose Our aim was to clarify the diagnostic impact of contrast-enhanced (CE)18 F-fluorodeoxyglucose (FDG)–positron emission tomography (PET)/computed tomography (CT) for staging of pancreatic cancer compared to non-CE PET/CT. Method and materials Between April 2006 and November 2009, a total of 95 patients (age range, 36–83 years [mean age, 67]) with primary pancreatic cancer underwent18 F-FDG PET/CT examinations. Diagnostic accuracy was compared between non-CE PET/CT and CE PET/CT. Images were analyzed visually and quantitatively by two blinded reviewers. Reference standard was histological examination in 48 patients (51%) and/or confirmation of an obvious progression in number and/or size of the lesions on follow-up CT examinations in 47 patients (49%). Results For T-staging, invasion of duodenum ( n = 20, 21%), mesentery ( n = 12, 13%), and retroperitoneum ( n = 13, 14%) was correctly diagnosed by both modalities. The ROC analyses revealed that the Az values of celiac artery (CA), common hepatic artery (CHA), splenic artery (SV), and superior mesenteric vein (SMV) invasion were significantly higher in the CE PET/CT group for both readers. Nodal metastasis was correctly diagnosed by CE PET/CT in 38 patients (88%) and by non-CE PET/CT in 45 patients (87%). Diagnostic accuracies of nodal metastasis in two modalities were similar. Using CE PET/CT, distant metastasis, scalene node metastasis, and peritoneal dissemination were correctly assigned in 39 patients (91%), while interpretation based on non-CE PET/CT revealed distant metastasis, scalene node metastasis, and peritoneal dissemination in 42 patients (81%). Diagnostic accuracy of distant metastasis, scalene node metastasis, and peritoneal dissemination with CE PET/CT was significantly higher than that of non-CE PET/CT ( p < 0.05). Conclusion CE PET/CT allows a more precise assessment of distant metastasis, scalene node metastasis, and peritoneal dissemination in patients with pancreatic cancer. |
---|---|
AbstractList | Our aim was to clarify the diagnostic impact of contrast-enhanced (CE) (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) for staging of pancreatic cancer compared to non-CE PET/CT.
Between April 2006 and November 2009, a total of 95 patients (age range, 36-83 years [mean age, 67]) with primary pancreatic cancer underwent (18)F-FDG PET/CT examinations. Diagnostic accuracy was compared between non-CE PET/CT and CE PET/CT. Images were analyzed visually and quantitatively by two blinded reviewers. Reference standard was histological examination in 48 patients (51%) and/or confirmation of an obvious progression in number and/or size of the lesions on follow-up CT examinations in 47 patients (49%).
For T-staging, invasion of duodenum (n=20, 21%), mesentery (n=12, 13%), and retroperitoneum (n=13, 14%) was correctly diagnosed by both modalities. The ROC analyses revealed that the Az values of celiac artery (CA), common hepatic artery (CHA), splenic artery (SV), and superior mesenteric vein (SMV) invasion were significantly higher in the CE PET/CT group for both readers. Nodal metastasis was correctly diagnosed by CE PET/CT in 38 patients (88%) and by non-CE PET/CT in 45 patients (87%). Diagnostic accuracies of nodal metastasis in two modalities were similar. Using CE PET/CT, distant metastasis, scalene node metastasis, and peritoneal dissemination were correctly assigned in 39 patients (91%), while interpretation based on non-CE PET/CT revealed distant metastasis, scalene node metastasis, and peritoneal dissemination in 42 patients (81%). Diagnostic accuracy of distant metastasis, scalene node metastasis, and peritoneal dissemination with CE PET/CT was significantly higher than that of non-CE PET/CT (p<0.05).
CE PET/CT allows a more precise assessment of distant metastasis, scalene node metastasis, and peritoneal dissemination in patients with pancreatic cancer. Our aim was to clarify the diagnostic impact of contrast-enhanced (CE) 18F-fluorodeoxyglucose (FDG)–positron emission tomography (PET)/computed tomography (CT) for staging of pancreatic cancer compared to non-CE PET/CT. Between April 2006 and November 2009, a total of 95 patients (age range, 36–83 years [mean age, 67]) with primary pancreatic cancer underwent 18F-FDG PET/CT examinations. Diagnostic accuracy was compared between non-CE PET/CT and CE PET/CT. Images were analyzed visually and quantitatively by two blinded reviewers. Reference standard was histological examination in 48 patients (51%) and/or confirmation of an obvious progression in number and/or size of the lesions on follow-up CT examinations in 47 patients (49%). For T-staging, invasion of duodenum (n=20, 21%), mesentery (n=12, 13%), and retroperitoneum (n=13, 14%) was correctly diagnosed by both modalities. The ROC analyses revealed that the Az values of celiac artery (CA), common hepatic artery (CHA), splenic artery (SV), and superior mesenteric vein (SMV) invasion were significantly higher in the CE PET/CT group for both readers. Nodal metastasis was correctly diagnosed by CE PET/CT in 38 patients (88%) and by non-CE PET/CT in 45 patients (87%). Diagnostic accuracies of nodal metastasis in two modalities were similar. Using CE PET/CT, distant metastasis, scalene node metastasis, and peritoneal dissemination were correctly assigned in 39 patients (91%), while interpretation based on non-CE PET/CT revealed distant metastasis, scalene node metastasis, and peritoneal dissemination in 42 patients (81%). Diagnostic accuracy of distant metastasis, scalene node metastasis, and peritoneal dissemination with CE PET/CT was significantly higher than that of non-CE PET/CT (p<0.05). CE PET/CT allows a more precise assessment of distant metastasis, scalene node metastasis, and peritoneal dissemination in patients with pancreatic cancer. Abstract Purpose Our aim was to clarify the diagnostic impact of contrast-enhanced (CE)18 F-fluorodeoxyglucose (FDG)–positron emission tomography (PET)/computed tomography (CT) for staging of pancreatic cancer compared to non-CE PET/CT. Method and materials Between April 2006 and November 2009, a total of 95 patients (age range, 36–83 years [mean age, 67]) with primary pancreatic cancer underwent18 F-FDG PET/CT examinations. Diagnostic accuracy was compared between non-CE PET/CT and CE PET/CT. Images were analyzed visually and quantitatively by two blinded reviewers. Reference standard was histological examination in 48 patients (51%) and/or confirmation of an obvious progression in number and/or size of the lesions on follow-up CT examinations in 47 patients (49%). Results For T-staging, invasion of duodenum ( n = 20, 21%), mesentery ( n = 12, 13%), and retroperitoneum ( n = 13, 14%) was correctly diagnosed by both modalities. The ROC analyses revealed that the Az values of celiac artery (CA), common hepatic artery (CHA), splenic artery (SV), and superior mesenteric vein (SMV) invasion were significantly higher in the CE PET/CT group for both readers. Nodal metastasis was correctly diagnosed by CE PET/CT in 38 patients (88%) and by non-CE PET/CT in 45 patients (87%). Diagnostic accuracies of nodal metastasis in two modalities were similar. Using CE PET/CT, distant metastasis, scalene node metastasis, and peritoneal dissemination were correctly assigned in 39 patients (91%), while interpretation based on non-CE PET/CT revealed distant metastasis, scalene node metastasis, and peritoneal dissemination in 42 patients (81%). Diagnostic accuracy of distant metastasis, scalene node metastasis, and peritoneal dissemination with CE PET/CT was significantly higher than that of non-CE PET/CT ( p < 0.05). Conclusion CE PET/CT allows a more precise assessment of distant metastasis, scalene node metastasis, and peritoneal dissemination in patients with pancreatic cancer. PURPOSEOur aim was to clarify the diagnostic impact of contrast-enhanced (CE) (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) for staging of pancreatic cancer compared to non-CE PET/CT.METHOD AND MATERIALSBetween April 2006 and November 2009, a total of 95 patients (age range, 36-83 years [mean age, 67]) with primary pancreatic cancer underwent (18)F-FDG PET/CT examinations. Diagnostic accuracy was compared between non-CE PET/CT and CE PET/CT. Images were analyzed visually and quantitatively by two blinded reviewers. Reference standard was histological examination in 48 patients (51%) and/or confirmation of an obvious progression in number and/or size of the lesions on follow-up CT examinations in 47 patients (49%).RESULTSFor T-staging, invasion of duodenum (n=20, 21%), mesentery (n=12, 13%), and retroperitoneum (n=13, 14%) was correctly diagnosed by both modalities. The ROC analyses revealed that the Az values of celiac artery (CA), common hepatic artery (CHA), splenic artery (SV), and superior mesenteric vein (SMV) invasion were significantly higher in the CE PET/CT group for both readers. Nodal metastasis was correctly diagnosed by CE PET/CT in 38 patients (88%) and by non-CE PET/CT in 45 patients (87%). Diagnostic accuracies of nodal metastasis in two modalities were similar. Using CE PET/CT, distant metastasis, scalene node metastasis, and peritoneal dissemination were correctly assigned in 39 patients (91%), while interpretation based on non-CE PET/CT revealed distant metastasis, scalene node metastasis, and peritoneal dissemination in 42 patients (81%). Diagnostic accuracy of distant metastasis, scalene node metastasis, and peritoneal dissemination with CE PET/CT was significantly higher than that of non-CE PET/CT (p<0.05).CONCLUSIONCE PET/CT allows a more precise assessment of distant metastasis, scalene node metastasis, and peritoneal dissemination in patients with pancreatic cancer. |
Author | Endo, Itaru Inoue, Tomio Tateishi, Ukihide Yoneyama, Tomohiro |
Author_xml | – sequence: 1 fullname: Yoneyama, Tomohiro – sequence: 2 fullname: Tateishi, Ukihide – sequence: 3 fullname: Endo, Itaru – sequence: 4 fullname: Inoue, Tomio |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25043494$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUGLFDEQhYOsuLOjv0CQHL30bJJO0t2Cggy7q7CgsCN4CzVJzZq2JxmTbmX-vWln9aAHoSCheC-v8tUFOQsxICHPOVtxxvVlv8I-gVsJxuWKlRL6EVnwthFV04jmjCxYI1jFZPv5nFzk3DPGlOzEE3IuFJO17OSCDHcj3PtwT8HaKYE90rijBwg2IYzeUluumF7RddwfIPkcA93i-AMx0DJOZWMYE-SxwvBlVjoKwdF_ux-vNpfrzVPyeAdDxmcP55J8ur7arN9Vtx9u3q_f3lZWST1WUnYNl9KBs41Uzrai6RxsBWoEqDvlWoEdWinAKQey7bTegmjbuisuYE29JC9P7x5S_DZhHs3eZ4vDAAHjlA1XmqlW1gXCktQnqU0x54Q7c0h-D-loODMzZtObX5jNjNmwUkIX14uHgGm7R_fH85trEbw-CbB887vHZLL1OKPwCe1oXPT_CXjzl98OPngLw1c8Yu7jlEIhaLjJwjBzN296XjSXjAmhVf0TDAWmhg |
CitedBy_id | crossref_primary_10_3390_diagnostics10110952 crossref_primary_10_1007_s00247_017_4019_2 crossref_primary_10_3390_cancers13164155 crossref_primary_10_1097_RCT_0000000000000323 crossref_primary_10_1002_14651858_CD011515_pub2 crossref_primary_10_1093_qjmed_hcu193 crossref_primary_10_1007_s00261_017_1410_2 crossref_primary_10_1016_j_clon_2023_01_018 crossref_primary_10_1055_a_1856_7346 crossref_primary_10_1097_MNM_0000000000001453 crossref_primary_10_1007_s00330_016_4708_5 crossref_primary_10_21053_ceo_2015_01424 crossref_primary_10_1007_s11605_017_3627_3 crossref_primary_10_3390_diagnostics10121042 crossref_primary_10_1097_MD_0000000000021829 crossref_primary_10_3310_hta22070 crossref_primary_10_1016_j_diii_2019_07_006 crossref_primary_10_1016_j_mednuc_2018_12_018 |
Cites_doi | 10.1016/j.ejrad.2009.09.026 10.1007/s11307-009-0271-7 10.1016/j.ctrv.2012.09.008 10.3748/wjg.v13.i27.3662 10.2174/138161211796957427 10.2214/ajr.168.6.9168704 10.2967/jnumed.108.051466 10.1097/01.sla.0000258608.52615.5a 10.1097/PPO.0b013e318274a461 10.1016/j.surg.2005.06.044 10.4329/wjr.v5.i3.98 10.1111/j.1440-1746.2010.06525.x 10.3322/canjclin.53.1.5 10.1097/MPA.0b013e3182550d77 |
ContentType | Journal Article |
Copyright | Elsevier Ireland Ltd 2014 Elsevier Ireland Ltd Copyright © 2014 Elsevier Ireland Ltd. All rights reserved. |
Copyright_xml | – notice: Elsevier Ireland Ltd – notice: 2014 Elsevier Ireland Ltd – notice: Copyright © 2014 Elsevier Ireland Ltd. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.ejrad.2014.04.026 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1872-7727 |
EndPage | 1739 |
ExternalDocumentID | 10_1016_j_ejrad_2014_04_026 25043494 S0720048X14002265 1_s2_0_S0720048X14002265 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GroupedDBID | - 0R 1 1- 1B1 1P 1RT 1~. 1~5 29G 4.4 457 4CK 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8P 9JM AABNK AACTN AAEDT AAIAV AAIKJ AAKOC AALMO AALRI AAOAW AAQFI AAQXK AAWTL AAXUO ABBQC ABFLS ABFNM ABLJU ABLVK ABMAC ABMZM ABPIF ABPTK ABXDB ABYKQ ACDAQ ACIUM ACRLP ADALY ADBBV ADEZE AEBSH AEKER AENEX AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FO G- G-2 G-Q GBLVA GJ HEI HMK HMO HVGLF HZ IHE IPNFZ J1W K KOM LCYCR M M29 M41 MO0 N9A O-L O9- OAUVE OI OU0 OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SDF SDG SEL SES SEW SPCBC SSH SSZ T5K UV1 WUQ Z5R ZA5 ZGI --- --K --M .1- .FO .GJ .~1 0R~ 1P~ 8P~ AAEDW ABJNI ADMUD AXJTR EFLBG FYGXN HZ~ OI~ ~G- AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c546t-4497144dadc745dc8279dab2e6eaa395d82e9ec42ad5da48966ba28839144a073 |
IEDL.DBID | AIKHN |
ISSN | 0720-048X |
IngestDate | Sat Oct 05 05:36:47 EDT 2024 Thu Sep 26 17:48:03 EDT 2024 Sat Sep 28 08:02:15 EDT 2024 Fri Feb 23 02:30:56 EST 2024 Thu Aug 18 17:15:50 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | Contrast-enhanced Pancreatic cancer PET/CT |
Language | English |
License | Copyright © 2014 Elsevier Ireland Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c546t-4497144dadc745dc8279dab2e6eaa395d82e9ec42ad5da48966ba28839144a073 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 25043494 |
PQID | 1560584304 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1560584304 crossref_primary_10_1016_j_ejrad_2014_04_026 pubmed_primary_25043494 elsevier_sciencedirect_doi_10_1016_j_ejrad_2014_04_026 elsevier_clinicalkeyesjournals_1_s2_0_S0720048X14002265 |
PublicationCentury | 2000 |
PublicationDate | 2014-10-01 |
PublicationDateYYYYMMDD | 2014-10-01 |
PublicationDate_xml | – month: 10 year: 2014 text: 2014-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland |
PublicationTitle | European journal of radiology |
PublicationTitleAlternate | Eur J Radiol |
PublicationYear | 2014 |
Publisher | Elsevier Ireland Ltd |
Publisher_xml | – name: Elsevier Ireland Ltd |
References | Jemal, Murray, Samuels, Ghafoor, Ward, Thun (bib0005) 2003; 53 Kitajima, Murakami, Yamasaki, Kaji, Shimoda, Kubota (bib0060) 2010; 12 Lu, Reber, Krasny, Kadell, Sayre (bib0080) 1997; 168 Tamm, Bhosale, Vikram, de Almeida Marcal, Balachandran (bib0025) 2013; 5 Buchs, Bühler, Bucher, Willi, Frossard, Roth (bib0050) 2011; 26 Asagi, Ohta, Nasu, Tanada, Nadano, Nishimura (bib0040) 2013; 42 Hirano, Kondo, Hara, Ambo, Tanaka, Shichinohe (bib0070) 2007; 246 Boujaoude (bib0020) 2007; 13 Farnell, Pearson, Sarr, DiMagno, Burgart, Dahl (bib0065) 2005; 138 Tang, Huang, Liu, Liu, Treven, Song (bib0035) 2011; 78 Strobel, Heinrich, Bhure, Soyka, Veit-Haibach, Pestalozzi (bib0045) 2008; 49 Raman, Horton, Fishman (bib0030) 2012; 18 Takada, Kondo, Hirano, Miura (bib0075) 2011; 112 Belli, Cereda, Anand, Reni (bib0010) 2013; 39 Huang, Saluja, Dudeja (bib0015) 2011; 17 Strobel (10.1016/j.ejrad.2014.04.026_bib0045) 2008; 49 Buchs (10.1016/j.ejrad.2014.04.026_bib0050) 2011; 26 Jemal (10.1016/j.ejrad.2014.04.026_bib0005) 2003; 53 Boujaoude (10.1016/j.ejrad.2014.04.026_bib0020) 2007; 13 Raman (10.1016/j.ejrad.2014.04.026_bib0030) 2012; 18 Kitajima (10.1016/j.ejrad.2014.04.026_bib0060) 2010; 12 Asagi (10.1016/j.ejrad.2014.04.026_bib0040) 2013; 42 Hirano (10.1016/j.ejrad.2014.04.026_bib0070) 2007; 246 Huang (10.1016/j.ejrad.2014.04.026_bib0015) 2011; 17 Belli (10.1016/j.ejrad.2014.04.026_bib0010) 2013; 39 Tamm (10.1016/j.ejrad.2014.04.026_bib0025) 2013; 5 Tang (10.1016/j.ejrad.2014.04.026_bib0035) 2011; 78 Farnell (10.1016/j.ejrad.2014.04.026_bib0065) 2005; 138 Takada (10.1016/j.ejrad.2014.04.026_bib0075) 2011; 112 Lu (10.1016/j.ejrad.2014.04.026_bib0080) 1997; 168 |
References_xml | – volume: 5 start-page: 98 year: 2013 end-page: 105 ident: bib0025 article-title: Imaging of pancreatic ductal adenocarcinoma: state of the art publication-title: World J Radiol contributor: fullname: Balachandran – volume: 49 start-page: 1408 year: 2008 end-page: 1413 ident: bib0045 article-title: Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer publication-title: J Nucl Med contributor: fullname: Pestalozzi – volume: 26 start-page: 657 year: 2011 end-page: 662 ident: bib0050 article-title: Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study publication-title: J Gastroenterol Hepatol contributor: fullname: Roth – volume: 112 start-page: 177 year: 2011 end-page: 181 ident: bib0075 article-title: Indications for and postoperative problems of distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer publication-title: Nihon Geka Gakkai Zasshi contributor: fullname: Miura – volume: 168 start-page: 1439 year: 1997 end-page: 1443 ident: bib0080 article-title: Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT publication-title: AJR Am J Roentgenol contributor: fullname: Sayre – volume: 12 start-page: 452 year: 2010 end-page: 459 ident: bib0060 article-title: Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT publication-title: Mol Imaging Biol contributor: fullname: Kubota – volume: 246 start-page: 46 year: 2007 end-page: 51 ident: bib0070 article-title: Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results publication-title: Ann Surg contributor: fullname: Shichinohe – volume: 42 start-page: 11 year: 2013 end-page: 19 ident: bib0040 article-title: Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence publication-title: Pancreas contributor: fullname: Nishimura – volume: 78 start-page: 142 year: 2011 end-page: 150 ident: bib0035 article-title: Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis publication-title: Eur J Radiol contributor: fullname: Song – volume: 18 start-page: 511 year: 2012 end-page: 522 ident: bib0030 article-title: Multimodality imaging of pancreatic cancer-computed tomography, magnetic resonance imaging, and positron emission tomography publication-title: Cancer J contributor: fullname: Fishman – volume: 17 start-page: 2221 year: 2011 end-page: 2238 ident: bib0015 article-title: Molecular targeted approaches for treatment of pancreatic cancer publication-title: Curr Pharm Des contributor: fullname: Dudeja – volume: 13 start-page: 3662 year: 2007 end-page: 3666 ident: bib0020 article-title: Role of endoscopic ultrasound in diagnosis and therapy of pancreatic adenocarcinomas publication-title: World J Gastroenterol contributor: fullname: Boujaoude – volume: 138 start-page: 618 year: 2005 end-page: 628 ident: bib0065 article-title: A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma publication-title: Surgery contributor: fullname: Dahl – volume: 39 start-page: 518 year: 2013 end-page: 524 ident: bib0010 article-title: Neoadjuvant therapy in resectable pancreatic cancer: a critical review publication-title: Cancer Treat Rev contributor: fullname: Reni – volume: 53 start-page: 5 year: 2003 end-page: 26 ident: bib0005 article-title: Cancer statistics, 2003 publication-title: CA Cancer J Clin contributor: fullname: Thun – volume: 78 start-page: 142 year: 2011 ident: 10.1016/j.ejrad.2014.04.026_bib0035 article-title: Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis publication-title: Eur J Radiol doi: 10.1016/j.ejrad.2009.09.026 contributor: fullname: Tang – volume: 12 start-page: 452 year: 2010 ident: 10.1016/j.ejrad.2014.04.026_bib0060 article-title: Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT publication-title: Mol Imaging Biol doi: 10.1007/s11307-009-0271-7 contributor: fullname: Kitajima – volume: 39 start-page: 518 year: 2013 ident: 10.1016/j.ejrad.2014.04.026_bib0010 article-title: Neoadjuvant therapy in resectable pancreatic cancer: a critical review publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2012.09.008 contributor: fullname: Belli – volume: 13 start-page: 3662 year: 2007 ident: 10.1016/j.ejrad.2014.04.026_bib0020 article-title: Role of endoscopic ultrasound in diagnosis and therapy of pancreatic adenocarcinomas publication-title: World J Gastroenterol doi: 10.3748/wjg.v13.i27.3662 contributor: fullname: Boujaoude – volume: 112 start-page: 177 year: 2011 ident: 10.1016/j.ejrad.2014.04.026_bib0075 article-title: Indications for and postoperative problems of distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer publication-title: Nihon Geka Gakkai Zasshi contributor: fullname: Takada – volume: 17 start-page: 2221 year: 2011 ident: 10.1016/j.ejrad.2014.04.026_bib0015 article-title: Molecular targeted approaches for treatment of pancreatic cancer publication-title: Curr Pharm Des doi: 10.2174/138161211796957427 contributor: fullname: Huang – volume: 168 start-page: 1439 year: 1997 ident: 10.1016/j.ejrad.2014.04.026_bib0080 article-title: Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.168.6.9168704 contributor: fullname: Lu – volume: 49 start-page: 1408 year: 2008 ident: 10.1016/j.ejrad.2014.04.026_bib0045 article-title: Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer publication-title: J Nucl Med doi: 10.2967/jnumed.108.051466 contributor: fullname: Strobel – volume: 246 start-page: 46 year: 2007 ident: 10.1016/j.ejrad.2014.04.026_bib0070 article-title: Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results publication-title: Ann Surg doi: 10.1097/01.sla.0000258608.52615.5a contributor: fullname: Hirano – volume: 18 start-page: 511 year: 2012 ident: 10.1016/j.ejrad.2014.04.026_bib0030 article-title: Multimodality imaging of pancreatic cancer-computed tomography, magnetic resonance imaging, and positron emission tomography publication-title: Cancer J doi: 10.1097/PPO.0b013e318274a461 contributor: fullname: Raman – volume: 138 start-page: 618 year: 2005 ident: 10.1016/j.ejrad.2014.04.026_bib0065 article-title: A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma publication-title: Surgery doi: 10.1016/j.surg.2005.06.044 contributor: fullname: Farnell – volume: 5 start-page: 98 year: 2013 ident: 10.1016/j.ejrad.2014.04.026_bib0025 article-title: Imaging of pancreatic ductal adenocarcinoma: state of the art publication-title: World J Radiol doi: 10.4329/wjr.v5.i3.98 contributor: fullname: Tamm – volume: 26 start-page: 657 year: 2011 ident: 10.1016/j.ejrad.2014.04.026_bib0050 article-title: Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2010.06525.x contributor: fullname: Buchs – volume: 53 start-page: 5 year: 2003 ident: 10.1016/j.ejrad.2014.04.026_bib0005 article-title: Cancer statistics, 2003 publication-title: CA Cancer J Clin doi: 10.3322/canjclin.53.1.5 contributor: fullname: Jemal – volume: 42 start-page: 11 year: 2013 ident: 10.1016/j.ejrad.2014.04.026_bib0040 article-title: Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence publication-title: Pancreas doi: 10.1097/MPA.0b013e3182550d77 contributor: fullname: Asagi |
SSID | ssj0005492 |
Score | 2.245469 |
Snippet | Abstract Purpose Our aim was to clarify the diagnostic impact of contrast-enhanced (CE)18 F-fluorodeoxyglucose (FDG)–positron emission tomography... Our aim was to clarify the diagnostic impact of contrast-enhanced (CE) 18F-fluorodeoxyglucose (FDG)–positron emission tomography (PET)/computed tomography (CT)... Our aim was to clarify the diagnostic impact of contrast-enhanced (CE) (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography... PURPOSEOur aim was to clarify the diagnostic impact of contrast-enhanced (CE) (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1734 |
SubjectTerms | Adult Aged Aged, 80 and over Contrast Media Contrast-enhanced Female Fluorodeoxyglucose F18 Humans Male Middle Aged Multimodal Imaging Neoplasm Staging Pancreatic cancer Pancreatic Neoplasms - diagnostic imaging Pancreatic Neoplasms - pathology PET/CT Positron-Emission Tomography Radiographic Image Interpretation, Computer-Assisted Radiology Radiopharmaceuticals Tomography, X-Ray Computed |
Title | Staging accuracy of pancreatic cancer: Comparison between non-contrast-enhanced and contrast-enhanced PET/CT |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0720048X14002265 https://dx.doi.org/10.1016/j.ejrad.2014.04.026 https://www.ncbi.nlm.nih.gov/pubmed/25043494 https://search.proquest.com/docview/1560584304 |
Volume | 83 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB6SDZReQpI-snmhQo9V1-uMH8otLAnbhoZCN7A3MZZkmhC8YR-HXPLbM5LlLSVtDwVfLCRLnpFmRujTNwAfM2vIJYmTdVXUEtmHSkKXypqdkas8wxQFts_rfHyDX6fZdANG3V0YD6uMtr-16cFax5JBlObg4fZ28CMpvIbLKW8R2BHl2SZssTtC7MHW-Zer8fUvpAeG3Mi-vvQNOvKhAPNyd3PyjKFDDJSnnmThzw7qbwFocESXO7AdI0hx3g5yFzZcswevvsUz8jdwz_GjzzwkyJjVnMyjmNWC13wbHhphvJ7nZ2K0zkAoIlhLNLNGBuw6LZbSNT8DOkBQY8XL0u8Xk8Fo8hZuLi8mo7GMORWkyTBfSkRVsIwsWVMgK6pMC2WpSl3uiE5VZsvUKWcwJZtZwpJ3QxX5jMSKWxHbg3fQ48G4fRCKa9ua17cxKdaqJI49lOEAiD9VV2Xeh0-dIPVDS52hO0zZnQ5y117uOuEn5epFJ2zd3QplO-YWcVEt9FAvUp3oF4rvQ75u-dvc0ewW_t3lh06pmleVPyqhxs1W3FXmj4vxNME-vG-1vf6HQPqGCg_-t9tDeO3fWkjgEfSW85U75tBmWZ3A5uen4UmcwM_f4_f3 |
link.rule.ids | 315,786,790,4521,24144,27957,27958,45620,45714 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7SDbS5lKbPbZNUhRwr1uuMH-otLAmb11LIBvYmxpJME4o37OOQf9-RLG8JaXso-CRLljwjzYzQp28ADjNryCWJk3VV1BLZh0pCl8qanZGrPMMUBbbPST6-wfNZNtuCUXcXxsMqo-1vbXqw1rFkEKU5uL-9HVwnhddwOeMtAjuiPHsG25gVQ-zB9vHZxXjyG-mBITeyry99g458KMC83N2CPGPoEAPlqSdZ-LOD-lsAGhzR6St4GSNIcdwOche2XPManl_FM_I38JPjR595SJAx6wWZBzGvBa_5Njw0wng9L76J0SYDoYhgLdHMGxmw67RcSdf8COgAQY0VT0u_n0wHo-lbuDk9mY7GMuZUkCbDfCURFYsILVlTICuqTAtlqUpd7oiOVGbL1ClnMCWbWcKSd0MV-YzEilsR24N30OPBuA8gFNe2Na9vY1KsVUkceyjDARB_qq7KvA9fO0Hq-5Y6Q3eYsjsd5K693HXCT8rVi07YursVynbMLeOiWuqhXqY60U8U34d80_LR3NHsFv7d5ZdOqZpXlT8qocbN19xV5o-L8SjBPrxvtb35h0D6hgo__m-3n-HFeHp1qS_PJhefYMe_aeGBe9BbLdZun8OcVXUQp_Ev2iL56Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Staging+accuracy+of+pancreatic+cancer%3A+Comparison+between+non-contrast-enhanced+and+contrast-enhanced+PET%2FCT&rft.jtitle=European+journal+of+radiology&rft.au=Yoneyama%2C+Tomohiro&rft.au=Tateishi%2C+Ukihide&rft.au=Endo%2C+Itaru&rft.au=Inoue%2C+Tomio&rft.date=2014-10-01&rft.issn=0720-048X&rft.volume=83&rft.issue=10&rft.spage=1734&rft.epage=1739&rft_id=info:doi/10.1016%2Fj.ejrad.2014.04.026&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ejrad_2014_04_026 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0720048X%2FS0720048X14X00100%2Fcov150h.gif |